TITLE:
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
Comparator: sitagliptin 100 mg

SUMMARY:

      The purpose of this study is to determine the safety and effectiveness of an investigational
      drug in patients with Type 2 Diabetes Mellitus.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  Patients at least 18 years of age and not older than 75 who have a specific type of
             diabetes called Type 2 Diabetes Mellitus

        Exclusion Criteria:

          -  Younger than 18 years of age or older than 75

          -  Any condition, which in the opinion of the investigator, may not be in the patient's
             best interest to participate
      
